Showing 961-970 of 6763 results for "".
Take 5: Clinically-Relevant Findings About Causes and Treatment of Rosacea
https://practicaldermatology.com/columns/take-5/take-5-clinically-relevant-findings-about-causes-and-treatment-of-rosacea/21870/Research sheds light on the pathogenesis of the disease and patients' experience.Business Advisor: Protect Your Practice With Online Reputation Management Strategies
https://practicaldermatology.com/topics/general-topics/business-advisor-protect-your-practice-with-online-reputation-management-strategies/21943/Online communication has affected how patients view physicians and practices. Learn how to know who is saying what about you on the Internet and what to do about itApocrine Hidrocystoma of the Axilla
https://practicaldermatology.com/issues/october-2025/apocrine-hidrocystoma-of-the-axilla-an-illustrative-case-and-literature-review/39757/An Illustrative Case and Literature ReviewThe Benefits of Private Practice: A Q&A with Joel Schlessinger, MD, FAAD
https://practicaldermatology.com/issues/september-2025/the-benefits-of-private-practice-a-qa-with-joel-schlessinger-md-faad/37630/While selling to and working for private equity–backed platforms may have its perks, many long-time private practitioners warn that the advantages of private practice are often not fully appreciated until it is too late. Practical Dermatology Chief Cosmetic Surgery Editor Emeritus Joel Schlessinger,What (More) Do You Want From Me? Reflections on Mentorship, Dermatology, and Moving Forward
https://practicaldermatology.com/issues/september-2025/what-more-do-you-want-from-me-reflections-on-mentorship-dermatology-and-moving-forward/37625/Professionally and personally, it’s hard to avoid the “what if” and “if only” scenarios. But when those thoughts outweigh the pride in where we’ve landed or who we’ve become, maybe it’s time to pause and appreciate the labor and sacrifices that got us here.First Reported Case of Red Face Response to Tralokinumab in the United States
https://practicaldermatology.com/issues/september-2025/first-reported-case-of-red-face-response-to-tralokinumab-in-the-united-states/37639/The chronic nature of atopic dermatitis (AD), which currently affects approximately 10.8% of children and 7.3% of adults in the United States,1 makes long-term management challenging.Mergers and Acquisitions in Derm and Aesthetics: Market Outlook
https://practicaldermatology.com/issues/september-2025/mergers-and-acquisitions-in-derm-and-aesthetics-market-outlook/37631/We took a deeper look into the dermatology and aesthetics mergers and acquisitions (M&A) market in a conversation with two of our team members, Drew Thomas and Jordan Frickle, who are closely involved in this sector. The following discussion brings together their perspectives on current trends,Redefining the Discourse: Psoriasis in Diverse Skin Tones
https://practicaldermatology.com/topics/psoriasis/redefining-the-discourse-psoriasis-in-diverse-skin-tones/23856/A lack of representation for underserved ethno-racial groups in clinical data and research is an underlying factor contributing to physicians’ challenges with effectively diagnosing and treating psoriasis in patients with diverse skin tones.From Hopelessness to Hope
https://practicaldermatology.com/topics/practice-management/from-hopelessness-to-hope/23657/New legislation aims to prevent physician suicide and burnout.Grow Your Practice Through Patient Retention
https://practicaldermatology.com/topics/practice-management/grow-your-practice-through-patient-retention/23567/Patients have many options when choosing where to go for aesthetic treaments. Learn strategies for turning your current patients into repeat customers.